ulcerative colitis Flashcards

1
Q

What is it and what are the characteristics

A
  • chronic inflammatory condition characterised by diffuse mucosal inflammation
  • relapsing remitting pattern
  • lifelong
  • associated with significant morbidity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pattern of inflammation

A
  • diffuse mucosal inflammation
  • pattern of inflammation is continuous, extending from rectum upwards to a varying degree
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most commonly presents in

A

15-25 years
but diagnosis can be made at any age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

common symptoms of active disease or relapse

A
  • bloody diarrhoea
  • abdominal pain
  • urgent need to poo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

complications

A
  • increased risk colorectal cancer
  • secondary osteoporosis
  • VTE
  • toxic megacolon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Severity classifications

A
  • mild, moderate or severe using the Truelove and Witt’s Severity Index to assess bowel movements, HR, ESR, pyrexia, melaena (tarry stools due to upper GI bleed) or anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anti-diarrhoeal drugs

A
  • Can sometimes use loperamide or codeine on advice of specialist
  • however contraindicated in acute UC as they can increase the risk of toxic megacolon!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Duration of CC course is usually

A

4-8 weeks depending on CC chosen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is proctitis

A

inflammation of rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is proctosigmoiditis

A

inflammation of rectum and signed colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is left sided colitis

A

disease involving the colon distal to the splenic flexure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is extensive colitis

A

affecting whole colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatment of acute mild to moderate UC: proctitis

A

proctitis = inflammation of rectum
- 1st line for initial presentation or inflammatory exacerbation is topical aminosalicylate
- if remission not achieved within 4 weeks, consider adding oral aminosalicylate
- if response inadequate, consider adding topical or oral CC for 4-8 weeks
- monotherapy with oral aminosalicylate can be considered for pt who prefer not to use enemas or suppositories, but this may not be as effective
- if remission not achieved within 4 weeks, consider + topical or oral CC for 4-8 weeks
- if aminosalicylate unsuitable, topical or oral CC for 4-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatment of acute mild to moderate UC: proctosigmviditis and left sided UC

A

-proctosigmoiditis: inflammation of rectum and sigmoid colon
- 1st line for initial presentation or inflammatory exacerbation: topical aminosalicylate
- if remission not achieved within 4 weeks, consider adding high dose oral aminosalicylate or switching to high dose oral aminosalicylate and 4-8 weeks topical CC
- if response remains inadequate, stop topical treatment and offer oral AS + 4-8 weeks of oral CC
- consider mono therapy with high dose oral AS in pt who prefer not to use enemas or suppositories, but this may not be as effective
- if no remission within 4 weeks, add oral CC for 4-8 weeks
- if AS unsuitable, consider topical or oral CC for 4-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatment of acute mild to moderate UC: extensive UC

A
  • 1st line for mild to moderate initial presentation or inflammatory exacerbation: topical + high dose oral AS
  • if no remission within 4 weeks, stop topical and offer high dose oral AS + 4-8 weeks oral CC
  • if AS unsuitable, consider oral CC 4-8 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment of acute moderate to severe UC

A
  • specialist care, the following can be used
  • janus kinase inhibitors
  • sphingosine-1-phosphate receptor modulators
  • biological drugs (e.g. anti-lymphocyte mabs, interleukin inhibitors, TNF-a inhibitors)
17
Q

treatment of acute severe UC

A
  • can be life threatening - medical emergency
  • immediate hospital admission
  • give IV CCs to induce remission whilst assessing need for surgery
  • if IV CCs contraindicated, declines or not tolerated, consider surgery or IV Cs (unlicensed)
  • 2nd line for pt who have little/no improvement within 72h IV CCs or symptoms worsen, combination of IV Cs + IV CCs or surgery
  • if Cs contraindicated or inappropriate, infliximab can be used
  • in pt who experience initial response to steroids followed by deterioration, take tool cultures to exclude presence of pathogens
  • consider cytomegalovirus activation
18
Q

maintaining remission in mild, moderate or severe UC

A
  • maintenance therapy with AS recommended in most pt
  • CCs not suitable due to their SE
19
Q

maintaining remission in mild, moderate or severe UC - after mild to moderate inflammatory exacerbation of proctitis or proctosigmoiditis

A
  • rectal AS started alone or in combo with oral AS
  • administered daily as part of intermittent regimen, e.e. 2-3x weekly or the first 7 days of each month
  • oral AS alone in pt who prefer not to sue enemas or suppositories, although this may not be as effective
20
Q

maintaining remission in mild, moderate or severe UC - after mild to moderate inflammatory exacerbation of left sided or extensive UC

A

low dose oral AS

21
Q

single daily doses vs multiple daily dosing

A

When used to maintain remission, single daily doses of oral aminosalicylates can be more effective than multiple daily dosing, but may result in more SE

22
Q

when can oral azathioprine, mercaptopurine (unlicensed) or MTX be used to maintain remission

A

IF
- there has been 2 or more inflammatory exacerbations in a 12 month period that required treatment with systemic CCs
- If remission is not maintained by aminosalicylates
- Or following a single acute severe episode
- No evidence to support use of MTX to induce or maintain remission in UC, though its use is common in clinical practice

23
Q

specialist treatments for remission

A
  • BIOLOGICAL DRUGS, JANUS KINASE INHIBITORS, AND SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORS FOR MAINTAINING REMISSION OF UC
  • Treatment with these agents may be continued into the maintenance phase
24
Q

non drug treatment

A
  • Surgery may be necessary as emergency treatment for severe UC that does not respond to drug treatment
  • Pt can also choose to have elective surgery for unresponsive or freq relapsing disease that is affecting their QoL